Bromodomains: Structure, function and pharmacology of inhibition

被引：168

作者：

Ferri, Elena ^{[1
]}

Petosa, Carlo ^{[2
,3
,4
]}

McKenna, Charles E. ^{[1
]}

机构：

[1] Univ So Calif, Dept Chem, Dana & David Dornsife Coll Letters Arts & Sci, Univ Pk Campus, Los Angeles, CA 90089 USA

[2] Univ Grenoble Alpes, Inst Biol Struct, 71 Ave Martyrs, F-38044 Grenoble, France

[3] CNRS, IBS, F-38044 Grenoble, France

[4] Commissariat Energie Atom & Energies Alternat, IBS, F-38044 Grenoble, France

来源：

BIOCHEMICAL PHARMACOLOGY | 2016年 / 106卷

关键词：

Bromodomains; Acetylated histones; BET proteins; Epigenetic drugs; Drug discovery; SMALL-MOLECULE INHIBITORS; FRAGMENT-BASED DISCOVERY; TRANSCRIPTIONAL ACTIVITY; CBP/P300; BROMODOMAIN; SELECTIVE-INHIBITION; SYNERGISTIC ACTIVITY; DISPLACEMENT ASSAYS; EPIGENETIC READERS; DRUG DISCOVERY; CHEMICAL PROBE;

D O I：

10.1016/j.bcp.2015.12.005

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Bromodomains are epigenetic readers of histone acetylation involved in chromatin remodeling and transcriptional regulation. The human proteome comprises 46 bromodomain-containing proteins with a total of 61 bromodomains, which, despite highly conserved structural features, recognize a wide array of natural peptide ligands. Over the past five years, bromodomains have attracted great interest as promising new epigenetic targets for diverse human diseases, including inflammation, cancer, and cardiovascular disease. The demonstration in 2010 that two small molecule compounds, JQ1 and I-BET762, potently inhibit proteins of the bromodomain and extra-terminal (BET) family with translational potential for cancer and inflammatory disease sparked intense efforts in academia and pharmaceutical industry to develop novel bromodomain antagonists for therapeutic applications. Several BET inhibitors are already in clinical trials for hematological malignancies, solid tumors and cardiovascular disease. Currently, the field faces the challenge of single-target selectivity, especially within the BET family, and of overcoming problems related to the development of drug resistance. At the same time, new trends in bromodomain inhibitor research are emerging, including an increased interest in non-BET bromodomains and a focus on drug synergy with established antitumor agents to improve chemotherapeutic efficacy. This review presents an updated view of the structure and function of bromodomains, traces the development of bromodomain inhibitors and their potential therapeutic applications, and surveys the current challenges and future directions of this vibrant new field in drug discovery. (C) 2015 Elsevier Inc. All rights reserved.

引用

页码：1 / 18

页数：18

共 169 条

[41] Structure Enabled Design of BAZ2-ICR, A Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B [J].

Drouin, Ludovic ;

McGrath, Sally ;

Vidler, Lewis R. ;

Chaikuad, Apirat ;

Monteiro, Octovia ;

Tallant, Cynthia ;

Philpott, Martin ;

Rogers, Catherine ;

Fedorov, Oleg ;

Liu, Manjuan ;

Akhtar, Wasim ;

Hayes, Angela ;

Raynaud, Florence ;

Mueller, Susanne ;

Knapp, Stefan ;

Hoelder, Swen .

JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (05) :2553-2559

[42] Discovery of a new chemical series of BRD4(1) inhibitors using protein-ligand docking and structure-guided design [J].

Duffy, Bryan C. ;

Liu, Shuang ;

Martin, Gregory S. ;

Wang, Ruifang ;

Hsia, Ming Min ;

Zhao, He ;

Guo, Cheng ;

Ellis, Michael ;

Quinn, John F. ;

Kharenko, Olesya A. ;

Norek, Karen ;

Gesner, Emily M. ;

Young, Peter R. ;

McLure, Kevin G. ;

Wagner, Gregory S. ;

Lakshminarasimhan, Damodharan ;

White, Andre ;

Suto, Robert K. ;

Hansen, Henrik C. ;

Kitchen, Douglas B. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (14) :2818-2823

[43] Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers [J].

Emadali, Anouk ;

Rousseaux, Sophie ;

Bruder-Costa, Juliana ;

Rome, Claire ;

Duley, Samuel ;

Hamaidia, Sieme ;

Betton, Patricia ;

Debernardi, Alexandra ;

Leroux, Dominique ;

Bernay, Benoit ;

Kieffer-Jaquinod, Sylvie ;

Combes, Florence ;

Ferri, Elena ;

McKenna, Charles E. ;

Petosa, Carlo ;

Bruley, Christophe ;

Garin, Jerome ;

Ferro, Myriam ;

Gressin, Remy ;

Callanan, Mary B. ;

Khochbin, Saadi .

EMBO MOLECULAR MEDICINE, 2013, 5 (08) :1180-1195

[44] Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors [J].

Ember, Stuart W. J. ;

Zhu, Jin-Yi ;

Olesen, Sanne H. ;

Martin, Mathew P. ;

Becker, Andreas ;

Berndt, Norbert ;

Georg, Gunda I. ;

Schoenbrunn, Ernst .

ACS CHEMICAL BIOLOGY, 2014, 9 (05) :1160-1171

[45] [1,2,4]Triazolo[4,3-a]phthalazines: Inhibitors of Diverse Bromodomains [J].

Fedorov, Oleg ;

Lingard, Hannah ;

Wells, Chris ;

Monteiro, Octovia P. ;

Picaud, Sarah ;

Keates, Tracy ;

Yapp, Clarence ;

Philpott, Martin ;

Martin, Sarah J. ;

Felletar, Ildiko ;

Marsden, Brian D. ;

Filippakopoulos, Panagis ;

Mueller, Susanne ;

Knapp, Stefan ;

Brennan, Paul E. .

JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (02) :462-476

[46] Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain [J].

Ferguson, Fleur M. ;

Fedorov, Oleg ;

Chaikuad, Apirat ;

Philpott, Martin ;

Muniz, Joao R. C. ;

Felletar, Ildiko ;

von Delft, Frank ;

Heightman, Tom ;

Knapp, Stefan ;

Abell, Chris ;

Ciulli, Alessio .

JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (24) :10183-10187

[47] Targeting bromodomains: epigenetic readers of lysine acetylation [J].

Filippakopoulos, Panagis ;

Knapp, Stefan .

NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (05) :339-358

[48] The bromodomain interaction module [J].

Filippakopoulos, Panagis ;

Knapp, Stefan .

FEBS LETTERS, 2012, 586 (17) :2692-2704

[49] Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family [J].

Filippakopoulos, Panagis ;

Picaud, Sarah ;

Mangos, Maria ;

Keates, Tracy ;

Lambert, Jean-Philippe ;

Barsyte-Lovejoy, Dalia ;

Felletar, Ildiko ;

Volkmer, Rudolf ;

Mueller, Susanne ;

Pawson, Tony ;

Gingras, Anne-Claude ;

Arrowsmith, Cheryl H. ;

Knapp, Stefan .

CELL, 2012, 149 (01) :214-231

[50] Selective inhibition of BET bromodomains [J].

Filippakopoulos, Panagis ;

Qi, Jun ;

Picaud, Sarah ;

Shen, Yao ;

Smith, William B. ;

Fedorov, Oleg ;

Morse, Elizabeth M. ;

Keates, Tracey ;

Hickman, Tyler T. ;

Felletar, Ildiko ;

Philpott, Martin ;

Munro, Shonagh ;

McKeown, Michael R. ;

Wang, Yuchuan ;

Christie, Amanda L. ;

West, Nathan ;

Cameron, Michael J. ;

Schwartz, Brian ;

Heightman, Tom D. ;

La Thangue, Nicholas ;

French, Christopher A. ;

Wiest, Olaf ;

Kung, Andrew L. ;

Knapp, Stefan ;

Bradner, James E. .

NATURE, 2010, 468 (7327) :1067-1073

← 1 2 3 4 5 6 7 8 9 10 →